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Enzyme mechanismAn assay has been developed in which the activity of an ubiquinol oxidase from Escherichia coli, cytochrome
bo3 (cbo3), is determined as a function of the hydrophobic substrate ubiquinol-10 (UQ-10) in tethered
bilayer lipid membranes (tBLMs). UQ-10 was added in situ, while the enzyme activity and the UQ-10
concentration in the membrane have been determined by cyclic voltammetry. Cbo3 is inhibited by UQ-10 at
concentrations above 5–10 pmol/cm2, while product inhibition is absent. Cyclic voltammetry has also been
used to characterise the effects of three inhibitors; cyanide, inhibiting oxygen reduction; 2-n-Heptyl-4-
hydroxyquinoline N-oxide (HQNO), inhibiting the quinone oxidation and Zn(II), thought to block the proton
channels required for oxygen reduction and proton pumping activity. The electrochemical behaviour of cbo3
inhibited with HQNO and Zn(II) is almost identical, suggesting that Zn(II) ions inhibit the enzyme reduction
by quinol, rather than oxygen reduction. This suggests that at Zn(II) concentration below 50 µM the proton
release of cbo3 is inhibited, but not the proton uptake required to reduce oxygen to water.olecular Systems, University of
).
l rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Bacteria have highly diverse and highly branched respiratory
chains [1] which consist of a range of enzymes which transfer
electrons from many different substrates into a common pool of lipid
soluble electron carriers, known collectively as quinones. There are a
number of different quinones expressed in organisms including
ubiquinone or coenzyme Q, menaquinone and plastoquinone. The
composition of the quinone pool in the membrane is dependent on
the species and growth conditions. Generally, anaerobic and gram
positive bacteria tend to use menaquinones whereas aerobic gram
negative bacteria and eukaryotic membranes are predominantly
composed of ubiquinones [2]. Ubiquinone-8 is the predominant
electron carrier in aerobically grown Escherichia coli.
In the E. coli aerobic respiratory pathway there are two terminal
oxidases that catalyse the oxidation of ubiquinol to ubiquinone and
reduce molecular oxygen to water. Expression of cytochrome bo3
(cbo3) is the favoured terminal oxidase under high oxygen conditions
and cytochrome bd is expressed under microaerophilic condi-
tions [3,4]. Cbo3 is of particular interest as it is structurally related to
the eukaryotic cytochrome c oxidase [5]. In the catalytic cycle of cbo3,
1/2O2 is reduced to H2O for every ubiquinol that is oxidised and a total
of four protons are translocated across the membrane, two of which
come from the oxidation of ubiquinol and reduction of 1/2O2. Theremaining two are pumped through the protein in conjunction with
the catalytic cycle [6]. Cbo3 contains two ubiquinol binding sites, a low
afﬁnity site (QL), which binds the substrate ubiquinol for catalysis and
is in equilibrium with the free ubiquinone pool in the membrane, and
a high afﬁnity site (QH), which stabilises the semiquinone interme-
diate during catalysis and is not exchanged with the UQ pool in the
bilayer [7]. When the crystal structure of cbo3 was solved, no quinone
was found in the QH but the structure enabled the authors to suggest a
binding pocket [5]. This site was later conﬁrmed and further reﬁned
by mutagenenis and labelling studies in the group of Gennis [8–10].
The characterisation of transmembrane redox enzymes can be
problematic due to the atypical nature of their substrates. Analysis of
enzyme kinetics with hydrophobic substrates can be complicated by
incomplete knowledge of the true substrate concentration in the
membrane [11]. Long chain quinones such as UQ-10 are extremely
hydrophobic and rapidly aggregate in aqueous solution, so water
soluble substrate analogues such as UQ-1, UQ-2 and duroquinol are
commonly used to derive kinetic and mechanistic information. We
have developed a membrane model in which the activity of cbo3 can
be assayed under near native conditions in a tethered bilayer lipid
membrane (tBLM, Fig. 1) [12,13]. tBLMs are biomimetic surfaces that
were ﬁrst designed in the 90s as a model membrane system to study a
wide variety of membrane properties, ranging from the physical
chemistry of lipid membranes, ion transport through ion channels to
enzyme kinetics of membrane-bound oxidoreductases [14–16].
The general principle of a tBLM is based on a surface that is
modiﬁed with synthetic lipids, which consist of a lipid headgroup, a
linker moiety and a group that binds to the surface. In our system the
lipid headgroup is a cholesterol, the linker consists of three repeats of
Fig. 1. A schematic representation of the tBLM used in this work.
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When these modiﬁed surfaces are incubated with lipid vesicles, the
vesicles spread onto the modiﬁed surfaces and cover the synthetic
lipids with phospholipid layer and thus creating a bilayer. In our
system, the coverage of the synthetic cholesterol linker is reduced by
mixing it with 6-mercaptohexanol. Because the two thiol molecule
phase separates on the gold surface, cholesterol-free regions are
created with space for integral membrane proteins (Fig. 1, bottom)
[17]. A particularly important feature of this membrane model is that
the native, hydrophobic quinones can be incorporated in the bilayer.
We have previously shown that tBLMs can be used to study the
enzyme kinetics of quinone converting enzymes like cbo3 using
voltammetric methods [13,18,19]. In this method, ubiquinone in the
tBLM is electrochemically reduced by the electrode and after diffusion
to cbo3 ubiquinol is catalytically oxidised, creating a redox loop. By
measuring the electron consumption at the surface (the electrode
current), the enzyme activity is thus established. In the past we have
incorporated cbo3 by assembling the tBLM with proteoliposomes that
were prepared with puriﬁed enzyme [18]. More recently, we have
prepared tBLMs from total inner membrane extract from E. coli
[13,19]. The advantage of the latter system is that no complex or harsh
puriﬁcation procedures are used and that the protein of interest is
permanently retained within its natural membrane environment.
We have continued this previous work by developing an assay to
determine enzyme kinetics as a function of UQ-10 concentration in the
membrane. By adding UQ-10 in situ, higher concentration of UQ-10
can be reached thanwe reported previously [13].We have also carried
out inhibition studies to interpret and understand mechanisms and
behaviour of quinone converting enzymes. We present voltammetric
evidence of differentmodes of inhibition from three distinct inhibitors
which are known to bind to different sites of cbo3.2. Materials and methods
2.1. Materials
EO3-cholesteryl was made as previously described [20].
6-Mercaptohexanol (Fluka) was used without further puriﬁcation. All
solvents were of HPLC grade (Fisher) and used as received. 20 mM
MOPS buffer with 30 mM Na2SO4 adjusted to pH 7.4 was used for
the preparation of membrane extracts and all electrochemistry experi-
ments. For inhibition studies, ubiquinone-10 (Sigma) was made up of
1 mg/ml stock solution in chloroform and stored at−20 °C. E. coli polar
extract (Avanti)was stored in 5 mgdry aliquots storedunder nitrogen at
−20 °C. NaCN and ZnSO4were added from an aqueous stock solution of
5 and 10 mM, respectively. 2-n-Heptyl-4-hydroxyquinoline N-oxide
(HQNO, Alexis Biochemicals) wasmade up of a stock solution of 20 mM
in methanol and stored at−20 °C. For in situ titration of UQ-10, UQ-10
was made up of stock solutions of 500 nM, 5 µM, 50 µM, 500 µM and
5 mM in dimethyl sulfoxide (DMSO).
2.2. E. coli inner membrane puriﬁcation
E. coli inner membranes were prepared from strain GO105/pJRhisA
in which the cbo3 protein is overexpressed and no cytochrome bd is
present [21]. E. coliwas grown to mid-log phase at 37 °C with shaking
in LB medium supplemented with 500 µM CuSO4 and 100 µg/ml
carbenicillin. E. coli cells were harvested from the growth medium by
centrifugation at 12,000×g for 30 min and cell paste was frozen at
−20 °C overnight. Thawed E. coli cell paste was resuspended in
20 mMMOPS 30 mMNa2SO4 buffer at approximately 30 ml buffer per
10 g cell paste and passed through a cell disrupter two times at
35,000 psi. Cell debris was removed by centrifugation at 12,000×g for
30 min. The supernatant containing the membrane fraction was
centrifuged at 131,000×g for 2 h and the membrane pellet was
resuspended in 25% w/w sucrose-MOPS/Na2SO4 buffer. A 30% w/w to
55% w/w sucrose gradient with centrifugation at 131,000×g for 16 h
with no deceleration or breaking was used to separate the inner
membrane from the outer membrane. The inner membrane fraction
was removed from the sucrose gradient and washed several times
with buffer by centrifugation at 131,000×g for 2 h. The protein
concentration of the inner membrane preparation was determined
using a Schaffner–Weissman assay [22]. Inner membrane vesicles
were resuspended in buffer and stored in 5 mg/ml protein aliquots at
−80 °C.
2.3. Mixed vesicle preparation
For the inhibition studies 1%w/w ubiquinol-10 solutionwas added
to E. coli polar extract lipids and dried under nitrogen to form a
multilammelar ﬁlm on the sides of a glass vial. The lipid/UQ-10 ﬁlm
was resuspended in buffer (5 mg/ml) by vortexing. Lipid vesicles
were formed by extrusion through a track etchedmembrane (200 nm,
Avanti), mixedwith innermembrane vesicles (10% v/v) and subjected
to three rounds of freeze-thawing before passing through a track
etched membrane another 11 times. For membranes used in the in
situ UQ-10 titration, mixed vesicles were prepared as described but no
UQ-10 was added to the E. coli polar extract lipids.
2.4. Electrodes and tethered membrane formation
Template-stripped gold (TSG) surfaces were formed as previously
described [23]. Brieﬂy, 150 nm of gold was evaporated onto a clean,
polished siliconwafer. 12 mm by 12 mm clean glass microscope slides
were glued to the gold surface using Epo-tek 377 and cured for 2 h at
120 °C. Once cooled, the glass slides could be removed from the silicon
wafer to expose the template-stripped gold surface ready for the
formation of the self-assembled monolayer (SAM).
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0.11 mMEO3-cholesteryl and 0.89 mM6-mercaptohexanol in propanol
for 16 h. This forms a60%/40%EO3-cholesteryl/6-mercaptohexanol area
ratio on the surface which was checked with impedance spectroscopy
before each experiment [17]. The slides were rinsed with propanol and
methanol and dried under nitrogen before being incorporated into the
electrochemical cell.
To form tethered bilayer lipid membranes (tBLMs), mixed vesicles
were added to the SAM surface at a ﬁnal concentration of 0.5 mg/ml in
the presence of 10 mM CaCl2 and incubated for 2 h. The surface was
then rinsed several times with buffer and 1 mM EDTA to remove any
traces of calcium ions in the cell.
2.5. Electrochemistry
Electrochemical measurements were carried out in a glass
electrochemical cell which holds 2 ml of buffer and was thermostat-
ted at 20 °C. A saturated calomel electrode (SCE) or saturated Ag/AgCl
reference electrode was used as the reference electrode (Radiometer
Analytical) and a platinumwire was used as the counter electrode. All
potentials are quoted vs. the Standard Hydrogen Electrode (SHE). The
gold-SAM working electrode was secured at the open base of the
electrochemical cell in a PTFE electrode holder, exposing an electrode
area of 0.25 cm2. The electrochemical cell was housed in a Faraday
cage to minimise electrical noise and argon was used to purge the cell
of oxygen. For the in situ UQ-10 titration, the experimental apparatus
was stored and assembled inside a nitrogen ﬁlled glovebox (MBraun
MB 150 B-G) where the O2 levels were <1 ppm and air equilibrated
buffer was added to the electrochemical cell to give an oxygen
concentration of 100 µM, well in excess of the KM. Electrochemical
measurements were recorded using an Autolab (Ecochemie) electro-
chemical analyser with a PGSTAT30 potentiostat and a FRA2
frequency analyser. All cyclic voltammetry experiments were carried
out by holding the potential at 0.4 V for 5 s and cycling to−0.4 V and
back at a scan rate of 0.01 V/s.
For the in situ UQ-10 titration, the UQ-10 concentration within the
bilayer was monitored using cyclic voltammetry at 1 V/s scan rate. At
this high scan rate, the catalytic activity of the enzyme in the tBLM is
outrun and a clear peak is observed due to the UQ-10 reduction. The
area underneath the peak, determined by the software ‘Utils’, kindly
provided by Dr. H.A. Heering, was used to calculate the UQ-10
concentration in the tBLM.
For analysis of the inhibition data, the baseline of the CV was
determined from the fully inhibited trace (using the ‘Utils’ software)
and subsequently subtracted from all traces. To determine the IC50
values, the relative current at −0.35 V vs. SHE was taken from the
baseline corrected data, although no signiﬁcant difference was
observed between IC50 values determined using baseline corrected
data and the raw data.
3. Results
3.1. In situ titration of UQ-10
Titrations of UQ-10 into the electrochemical cell were tried with
several organic solvents, including ethanol and acetone. DMSO was
found to be the most suitable solvent for in situ addition as UQ-10 is
soluble in DMSO up to concentrations of 5 mM, DMSO easily mixes
with water and is non-volatile. The main drawback is that DMSO has
been suggested to disrupt and permeabilise cell membranes [24].
However, we did not observe a signiﬁcant disruption in the tBLM
(only a small decrease in double layer capacitance was observed
between 0 and 40% DMSO). Finally, no difference in the cbo3 activity
was observed with cyclic voltammetry when adding small amounts of
DMSO (<2%).Fig. 2A shows cyclic voltammograms (10 mV/s) of the tBLM at
increasing amounts of UQ-10. DMSO content stayed below 10% (v/v)
throughout the titration. As is clear from Fig. 2A, the UQ-10 addition
signiﬁcantly changes the shape of the cyclic voltammograms. At low
concentration, the shape remains largely unchanged, but the current
increases. At high concentration, the wave converts into a peak
shaped voltammogram, with the current at low potential (<−0.3 V
vs. SHE) decreasing. The peak is partly due to large amount of UQ-10
in the membrane, thus becoming more prominent relative to the
catalytic wave. Analysis of the peak area presented in the Discussion
section shows that this peak signal cannot be explained by UQ-10
reduction alone.
The reduction in current at low potential indicates that cbo3 is
inhibited by UQ-10, a property we could only tentatively conclude
previously due to scatter in the data [13], but is unambiguous from the
in situ titrations with UQ-10. Finally, Fig. 2A shows that the onset of
the wave occurs at higher potential when the UQ-10 concentration is
increased. This is not due to the DMSO, as no change in the CV is seen
upon addition of DMSO alone. The reason for this shift is explained in
the Discussion section.
Using fast-scan voltammetry, the relationship between the
concentration of UQ-10 in the electrolyte and the concentration
determined in the bilayer can be determined. At 1 V/s, the
voltammogram outruns catalysis and even at low UQ-10 concentra-
tions, the wave transforms to a peak corresponding to the UQ-10
reduction in the membrane. The area under the peak is used to
determine the UQ-10 coverage and the relation betweenUQ-10 added
to the electrolyte (in DMSO) and QU-10 incorporation in the
membrane is shown in the insert of Fig. 2A. This relation is
approximately linear, although the slope varies between experiments.
The quinone content in the membrane determined at 1 V/s is
observed to be lower than that at 10 mV/s (after inhibition of the
enzyme with NaCN). Approximately 50% of the UQ-10 signal is lost
when the scan rate is increased from 10 mV/s to 1 V/s. Previously, we
have reported that the diffusion of UQ-10 across the tethered
membrane is slow with a ‘ﬂip’ time between 0.05 and 1 s−1 [12].
We thus assume that the loss of signal in the fast-scan voltammetry is
due to the diffusion kinetics of the UQ-10 in the membrane.
The relative activity of cbo3 with different UQ-10 concentrations in
a tBLM at −0.35 V vs. SHE on the reverse scan of the CV is shown in
Fig. 2B (ﬁlled symbols). Correcting for the loss in apparent UQ-10
coverage between 10 mV/s and 1 V/s, the data ﬁts alongside data we
reported previously [13], in which UQ-10 was added to the lipid
vesicles prior to tBLM formation. In this latter approach, the UQ-10
content of the membrane was determined at 10 mV/s after inhibiting
the enzyme with NaCN.
3.2. Inhibition of cbo3
Besides the in situ titration of UQ-10, the interaction betweenUQ-10
and cbo3 has also been studied using inhibitors. Note that the cyclic
voltammogram contains direct information about this interaction, as at
each potential the enzyme activity (or current) is related to the quinol/
quinone ratio, which, when using slow scan rates, is in equilibrium
throughout the scan.
Cyanide is a well known and potent inhibitor of heme–copper
oxidases. It binds to the binuclear centre in cbo3 and prevents the
reduction of oxygen to water. Fig. 3, middle, shows the forward part of
the CVs collected after addition of NaCN. With increasing NaCN
concentration the size of the catalytic UQ wave decreases in
magnitude and then transforms to a peak shape. Closer examination
reveals that the addition of NaCN reduces the maximum current
without changing the onset of the wave. This results in a shift of the
midpoint of the wave, which is more clearly visible in the ﬁrst
derivative shown at the bottom of Fig. 3. This behaviour is identical
(albeit reversed) to the behaviour we have previously indentiﬁed
Fig. 2. (A) Cyclic voltammograms of a tBLM containing cbo3 at increasing UQ-10 coverage
(determinedseparately using cyclic voltammogramsat1 V/s). Electrodearea is∼0.25 cm2.
(A, insert) The UQ-10 coverage (determined using cyclic voltammograms at 1 V/s) as a
function of UQ-10 added to the electrolyte from a DMSO stock solution. (B) (closed
symbols) Normalised activity of cbo3 as a function of UQ-10 coverage for three different
experiments (squares, triangles and circles). The UQ-10 coverage (bottom axis) is
determined by determination of the UQ-10 peak area from voltammograms measured at
1 V/s. (Open symbols) Comparisonwith previously published data [13] inwhich UQ-10 is
co-solubilised in vesicles prior to tBLM formation and the UQ-10 coverage (top axis) is
determined at 10 mV/s after inhibition of cbo3 with NaCN. The top and bottom axes have
different scales due to observed differences in UQ-10 coverage when determined at 1 V/s
and 10 mV/s (see text).
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oxygen substrate concentrations [13], consistent with the fact that
the cyanide inhibits oxygen reduction. At high concentrations
(>50 µM) of NaCN, the enzyme is completely inhibited and no
further reduction of the peak is observed. The IC50 of NaCN with cbo3
in the native-like tBLM is 7.96±0.27 µM.
Cbo3 was also studied with the substrate analogue 2-n-Heptyl-4-
hydroxyquinoline N-oxide (HQNO), which is a napthoquinone
analogue of the semiquinone intermediate. As with the NaCN data, a
transition is observed from wave to peak upon increasing HQNO
concentration. However, in contrast to NaCN, the midpoints of the
wave remain unaltered. In the baseline corrected voltammograms, an
interesting double wave feature becomes apparent at high HQNO
concentration, which is due to the superposition of the quinol
reduction peak and the catalytic wave of reduced magnitude. As
with NaCN we ﬁnd that HQNO can completely and fully inhibit the
enzyme. The IC50 for HQNO is 28.7±2.1 µM.Zinc is known to be an inhibitor of a wide variety of bioenergetic
enzymes including cytochrome c oxidase [25,26], mitochondrial
complex I [27] and cbo3 [3]. As with the HQNO, the voltammograms
for partially inhibited cbo3 shows that themidpoint of thewave remains
unaltered, ultimately resulting in the double wave feature. The IC50 for
cbo3 with ZnSO4 is 20.6±3.6 µM. We note that the inhibition with
ZnSO4 showed some variability in the results, suggesting that the
detailed structural properties of the tBLM inﬂuences the Zn(II) enzyme
interaction.
4. Discussion
4.1. Substrate inhibition
Quinones are hydrophobic electron carriers and an essential
component of respiratory chains in all organisms to mediate electron
transfer between individual protein complexes. A signiﬁcant problem
in being able to fully understand and interpret the roles of quinones in
biological processes is the lack of appropriate, physiologically relevant
assays available. Currently, the most widespread methods are
spectrophotometric assays using short, water soluble quinone
analogues as long chain hydrophobic quinones can aggregate and
form micelles which increase the turbidity of the assay solution and
interfere with accurate measurements [28]. Another issue is the
determination of accurate and absolute quinone concentrations
partitioned into the cell membrane. By using model bilayers tethered
to an electrode the activity of quinoneswith transmembrane enzymes
can be easily and quickly monitored [29]. With this approach quinone
concentrations within the bilayer may be rapidly and accurately
determined using fast-scan voltammetric methods and the quinone
concentration can be changed in situ by the addition of ubiquinone
solubilised in DMSO. The in situ UQ-10 addition data presented here
corroborates our previously published data in that cbo3 is inhibited by
UQ-10. The shape of the voltammogram at high UQ-10 content
(apparent coverage of 23 pmol/cm2 at 1 V/s corresponds to
∼46 pmol/cm2 at 10 mV/s, Fig. 2A) shows a peak shape upon lowering
the potential in which the area underneath the peak far exceeds the
quinone content of membrane. This behaviour can be explained by
assuming substrate inhibition, but not product inhibition. At high
potential all UQ-10 is oxidised, thus not inhibiting cbo3. In the initial
stages of the catalytic wave, some UQ-10 is reduced and substrate
generated, but not yet to an extent that the enzyme is inhibited. Upon
reducing the potential further, more substrate is generated, inhibiting
the enzyme and thereby reducing the current, resulting in a peak
shaped voltammogram. Besides the catalytic wave, this peak shape is
further enhanced by the large amount of UQ-10 in the membrane as
this induces a UQ-10 reduction peak in itself. Modelling studies shown
in the Supporting information support this hypothesis. When both the
product and the substrate inhibit cbo3, the modelling shows the
expected behaviour that the area underneath the peak is equal or less
than the UQ-10 coverage, in contrast with our data in which the area
is larger than the UQ-10 coverage. However, when only substrate
inhibits cbo3 the model indicates that the peak area can exceed that of
the UQ-10 coverage.
The modelling studies also conﬁrm that by increasing the UQ-10 in
the tBLM, the onset of the catalytic wave shifts to more positive
potentials. The reason for this is complex, but can approximately be
explained by noting that at a given potential, a similar fraction of UQ-10
is in its reduced state. Higher coverage of UQ-10 will lead to larger
substrate concentration and thus a higher turn-over of the enzyme.
Substrate inhibition (without product inhibition) has been
observed previously by Musser et al. [30] for cbo3 using water soluble
quinone analogues, UQ-1 and UQ-2. Musser et al. could not exclude
that the observed kinetic properties were due to the high concentra-
tions of UQ-1 and UQ-2 used in the essays, which resulted in non-ideal
solution conditions. Although the data presented here conﬁrm the
Fig. 3. (Top) Cyclic voltammograms for cytochrome bo3 inhibited with (NaCN) at 0 µM, 5 µM, 10 µM, 20 µM, 30 µM and 90 µM, (HQNO) at 0 µM, 40 µM, 60 µM, 80 µM and 190 µM
and (ZnSO4) at 0 µM, 25 µM, 50 µM and 125 µM. The QU-10 concentration in the membrane is between 5 and 10 pmol/cm2. The electrode area is 0.25 cm2. (Middle) Baseline
corrected voltammograms of the data shown in the top. The baseline was taken from the cyclic voltammogram measured at the highest concentration of inhibitor. (Middle, insert)
Extracted data for IC50 determination. Error bars are standard deviations determined from at least three experiments. (Bottom) First derivatives of the data shown in the middle.
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inhibition is due to some non-ideal behaviour of the quinones in the
membrane such as aggregation of ubiquinone or disruption of the
lipid bilayer. However, no indication of non-ideal behaviour was
observed and the more likely explanation is that the enzyme is
subjected to substrate inhibition. It is possible that a second ubiquinol
binds close or at the active site (QL) during turn-over, disrupting the
catalytic reaction at this site. However, the fact that the inhibition is
speciﬁc to ubiquinol (and not ubiquinone) makes this less likely. An
alternativemodel was previously suggested; at high concentrations of
ubiquinol, the quinone in the high afﬁnity ubiquinone site, QH, is
replaced by an ubiquinol, making it impossible for the QH site to be
reduced to the semiquinone intermediate that is required during
turn-over [30,31]. The location of the QH site close to the surface of the
enzyme [5,8] suggests that it could be possible that the ubiquinone isreplaced. However, the quinone is known to be tightly bound and not
easily removed from the QH site, making it less likely that replacement
can occur at a fast rate. An alternative explanation is that at high
ubiquinol concentration in the membrane, ubiquinol binds close to
the QH site in an a-speciﬁc manner such that the ubiquinone in the QH
site is reduced to an ubiquinol. In this model, the inhibitionwould also
depend on the redox state of the ubiquinone pool or, in other words,
inhibition would only take place when most of the ubiquinol is in the
reduced state.
4.2. Inhibitor studies
Two distinct voltammetric behaviours are observed depending on
the type of compound used to inhibit cbo3. We hypothesise that this is
due to the inhibition of the two active sites in cbo3; the quinol
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respectively, see Fig. 4). NaCN, which induces a shift in the wave's
midpoints (Fig. 3), binds to the binuclear centre in the active site,
thereby directly reducing the oxygen reduction reaction (rate k2 in
Fig. 4). The other inhibitors, HQNO and ZnSO4, have a distinct
response and do not cause a shift in the midpoint of the catalytic
wave.
The effect of these inhibitors on the voltammograms can be
explained by taking into account that the total current is dependent
on both k1 and k2 with the slowest reaction being the rate limiting
step. The second important feature is that the rate k1 is dependent on
the redox state of the ubiquinone pool, which in turn is dependent on
the applied potential. Thus, at high potential (the onset of the wave),
little ubiquinol is reduced and thus k1 is low and rate limiting. At low
potential (the plateau region), all ubiquinol is reduced and the activity
is either limited by k1 or k2. Cyanide inhibits the oxygen reducing site
and thus lowers the rate k2. As a result, by increasing the cyanide
concentration, k2 will become rate limiting. The lower the rate of k2,
the higher the potential at which it becomes rate limiting (as the rate
k1 is dependent on potential). Increasing cyanide thus changes the
shape as well as the magnitude of the wave.
In contrast, HQNO reduces the rate k1 and if this is done in a truly
competitive manner, rate k1 will still be dependent on the oxidation
state of the quinone pool and thus the wave shape will remain
unaltered although themagnitude decreases. HQNO is indeed thought
to inhibit cbo3 competitively by binding at the QL site in the enzyme
[32,33] although kinetic analysis suggests that HQNO may actually be
an uncompetitive [30] or non competitive [34] inhibitor, possibly also
interactingwith the QH site. The IC50 value (∼21 µM) determined here
is considerably higher than previously determined values (0.3 µM)
[18]. We propose that this difference is due to the different assay
conditions used, changing the nature of the quinol substrate and
‘effective’ quinol and inhibitor concentration in the lipid environment.
Although during the cyclic voltammogram, the concentration of
substrate varies, differentiating between non competitive and
uncompetitive inhibition based on the cyclic voltammetry would
only be possible if the quinol oxidation is irreversible (if the reduction
potential of cbo3 is much lower than UQ-10). In contrast, the fact that
themidpoint of the catalytic wave remains unaltered upon addition of
HQNO can only be explained if cbo3 is in redox equilibrium with the
quinol/quinone pool in the membrane and the reduction of cbo3 is not
signiﬁcantly different from that of UQ-10. If this was not the case, the
onset of the catalytic wave would remain unchanged upon addition of
HQNO as in this situation the enzyme activity during the scan would
only be limited by the ubiquinol concentration and not inﬂuenced by
ubiquinone (or the ratio of ubiquinol/ubiquinone). Modelling studies
(Supporting information) indeed conﬁrm that the data can only be
simulated if a model is assumed in which cbo3 is in redox equilibrium
with the UQ-10 pool.
Zinc and other selective divalent cations, like cadmium, nickel and
cobalt [35,36] have been shown to inhibit heme–copper oxidases suchFig. 4. Schematic representation of the tBLM and the rates that inﬂuence the currents
measured with cyclic voltammetry.as cbo3 and cytochrome c oxidase. At low concentration, the cations
are thought to inhibit the enzymes by blocking the release of protons
[25,36]. The voltammograms after inhibition with HQNO and ZnSO4
showed a very similar behaviour contrasting that of NaCN. Especially
at the intermediate inhibitor concentrations, both inhibitors induce a
double wave effect in the voltammogram. These results thus conﬁrm
that Zn(II) inhibition is not affecting proton uptake to supply protons
for oxygen reduction, but mainly inhibits enzyme reduction by quinol
or the coupled release of protons (from quinol oxidation). This latter
observation might be inﬂuenced by the enzyme's orientation on the
surface. If the enzyme is oriented with the N-side towards the surface,
Zn(II) ions can only bind to the P-side, corresponding to the
impairment of proton release as shown for cytochrome c oxidase [25].
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